Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1985 - 1992 of 11454 results
TCPA Regulatory Update — Chairwoman Rosenworcel Circulates Declaratory Ruling on Ringless Voicemails
February 22, 2022| Article| Viewpoint
A Business Deal Could Kill Your Right to Challenge a Patent’s Validity
February 22, 2022| Blog| Viewpoint
TCPA Litigation Update — What Is a “Voice” Post-Facebook?
February 22, 2022| Article| Viewpoint
Minimizing Stockholder Litigation Risks
February 18, 2022| Blog| Viewpoint
DOJ Tells Cybercriminals, “If you continue to come for us we will come for you” and Warns Companies to Keep Their “Cyber Shields Up”
February 18, 2022| Blog| Viewpoint
Facebook to Pay $90 Million to Settle Data Privacy Lawsuit
February 18, 2022| Blog| Viewpoint
EXCLUSIVE RIGHTS: Intellectual Property — Domestic Industry at the ITC – The Commission Has Set a Positive Trend
February 18, 2022| Podcast| Viewpoint
(Updated) Congress Ends Mandatory Arbitration of Sexual Harassment and Sexual Assault Claims
February 18, 2022| Blog| Viewpoint
News & Press Releases
Mintz is pleased to announce that 31 attorneys have been named Massachusetts Super Lawyers and 35 attorneys have been named Massachusetts Rising Stars for 2024.
Mintz IP Group Named “Litigation Department of the Year” in 2024 New England Legal Awards
October 02, 2024
Mintz’s intellectual property litigation group was named “Litigation Department of the Year” for the IP specialty category in the 2024 New England Legal Awards. The awards recognize attorneys and firms in Connecticut, Maine, Vermont, New Hampshire, Massachusetts, and Rhode Island.
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.